63 related articles for article (PubMed ID: 24716936)
1. Population-based cervical screening outcomes in Turkey over a period of approximately nine and a half years with emphasis on results for women aged 30-34.
Sengul D; Altinay S; Oksuz H; Demirturk H; Korkmazer E
Asian Pac J Cancer Prev; 2014; 15(5):2069-74. PubMed ID: 24716936
[TBL] [Abstract][Full Text] [Related]
2. Evaluation of cervical screening results in a population at normal risk.
Karabulut A; Alan T; Ali Ekiz M; Iritaş A; Kesen Z; Yahşi S
Int J Gynaecol Obstet; 2010 Jul; 110(1):40-2. PubMed ID: 20362986
[TBL] [Abstract][Full Text] [Related]
3. Evaluation of cervical cytological abnormalities in Turkish population.
Atilgan R; Celik A; Boztosun A; Ilter E; Yalta T; Ozercan R
Indian J Pathol Microbiol; 2012; 55(1):52-5. PubMed ID: 22499301
[TBL] [Abstract][Full Text] [Related]
4. Prevalence of cervical cytological abnormalities in Turkey.
Turkish Cervical Cancer And Cervical Cytology Research Group
Int J Gynaecol Obstet; 2009 Sep; 106(3):206-9. PubMed ID: 19541303
[TBL] [Abstract][Full Text] [Related]
5. Benefits of Cervical Cancer Screening by Liquid-Based Cytology as Part of Routine Antenatal Assessment.
Parkpinyo N; Inthasorn P; Laiwejpithaya S; Punnarat T
Asian Pac J Cancer Prev; 2016; 17(9):4457-4461. PubMed ID: 27797261
[TBL] [Abstract][Full Text] [Related]
6. Cervical cytological screening results of 8,495 cases in Turkey--common inflammation but infrequent epithelial cell abnormalities?
Daloglu FT; Karakaya YA; Balta H; Altun E; Duman A
Asian Pac J Cancer Prev; 2014; 15(13):5127-31. PubMed ID: 25040962
[TBL] [Abstract][Full Text] [Related]
7. The prevelance of human papillomavirus (HPV) genotypes detected by PCR in women with normal and abnormal cervico-vaginal cytology.
Beyazit F; Sılan F; Gencer M; Aydin B; Paksoy B; Unsal MA; Ozdemir O
Ginekol Pol; 2018; 89(2):62-67. PubMed ID: 29512809
[TBL] [Abstract][Full Text] [Related]
8. Population-based prevalence of abnormal cervical cytology findings and local risk factors in Ibadan, Nigeria: implications for cervical cancer control programs and human papilloma virus immunization.
Thomas JO; Ojemakinde KO; Ajayi IO; Omigbodun AO; Fawole OI; Oladepo O
Acta Cytol; 2012; 56(3):251-8. PubMed ID: 22555526
[TBL] [Abstract][Full Text] [Related]
9. Screening test results associated with cancer diagnoses in 287 women with cervical squamous cell carcinoma.
Li Z; Austin RM; Guo M; Zhao C
Arch Pathol Lab Med; 2012 Dec; 136(12):1533-40. PubMed ID: 22900617
[TBL] [Abstract][Full Text] [Related]
10. Cytopathological pattern of cervical Pap smear according to the Bethesda system in Southwestern Saudi Arabia.
Elhakeem HA; Al-Ghamdi AS; Al-Maghrabi JA
Saudi Med J; 2005 Apr; 26(4):588-92. PubMed ID: 15900366
[TBL] [Abstract][Full Text] [Related]
11. Expression of the MN antigen in cervical papanicolaou smears is an early diagnostic biomarker of cervical dysplasia.
Liao SY; Stanbridge EJ
Cancer Epidemiol Biomarkers Prev; 1996 Jul; 5(7):549-57. PubMed ID: 8827360
[TBL] [Abstract][Full Text] [Related]
12. Prevalence and risk factors for human papillomavirus DNA in cervical cytology.
Kasap B; Yetimalar H; Keklik A; Yildiz A; Cukurova K; Soylu F
Eur J Obstet Gynecol Reprod Biol; 2011 Nov; 159(1):168-71. PubMed ID: 21764503
[TBL] [Abstract][Full Text] [Related]
13. [Quality and performance of pap smears in the cervical cancer screening program in a city of southern Brazil].
Uchimura NS; Nakano K; Nakano LC; Uchimura TT
Rev Assoc Med Bras (1992); 2009; 55(5):569-74. PubMed ID: 19918658
[TBL] [Abstract][Full Text] [Related]
14. Screening for cervical disease in mature women: strategies for improvement.
Colgan TJ; Clarke A; Hakh N; Seidenfeld A
Cancer; 2002 Aug; 96(4):195-203. PubMed ID: 12209660
[TBL] [Abstract][Full Text] [Related]
15. Effectiveness of cervical screening after age 60 years according to screening history: Nationwide cohort study in Sweden.
Wang J; Andrae B; Sundström K; Ploner A; Ström P; Elfström KM; Dillner J; Sparén P
PLoS Med; 2017 Oct; 14(10):e1002414. PubMed ID: 29065127
[TBL] [Abstract][Full Text] [Related]
16. Bacterial vaginosis, aerobic vaginitis, vaginal inflammation and major Pap smear abnormalities.
Vieira-Baptista P; Lima-Silva J; Pinto C; Saldanha C; Beires J; Martinez-de-Oliveira J; Donders G
Eur J Clin Microbiol Infect Dis; 2016 Apr; 35(4):657-64. PubMed ID: 26810061
[TBL] [Abstract][Full Text] [Related]
17. Prevalence of high-risk human papillomavirus (HR-HPV) infection among women with normal and abnormal cervical cytology in Myanmar.
Mu-Mu-Shwe ; Harano T; Okada S; Aye-Aye-Win ; Khin-Saw-Aye ; Hlaing-Myat-Thu ; Mo-Mo-Win ; Khin-Khin-Oo ; Myo-Khin
Acta Med Okayama; 2014; 68(2):79-87. PubMed ID: 24743783
[TBL] [Abstract][Full Text] [Related]
18. History of high-risk HPV and Pap test results in a large cohort of patients with invasive cervical carcinoma: experience from the largest women's hospital in China.
Tao X; Griffith CC; Zhou X; Wang Z; Yan Y; Li Z; Zhao C
Cancer Cytopathol; 2015 Jul; 123(7):421-7. PubMed ID: 25955972
[TBL] [Abstract][Full Text] [Related]
19. Comparison of HPV test versus conventional and automation-assisted Pap screening as potential screening tools for preventing cervical cancer.
Nieminen P; Vuorma S; Viikki M; Hakama M; Anttila A
BJOG; 2004 Aug; 111(8):842-8. PubMed ID: 15270934
[TBL] [Abstract][Full Text] [Related]
20. Performance of visual inspection with acetic acid and human papillomavirus testing for detection of high-grade cervical lesions in HIV positive and HIV negative Tanzanian women.
Dartell MA; Rasch V; Iftner T; Kahesa C; Mwaiselage JD; Junge J; Gernow A; Ejlersen SF; Munk C; Kjaer SK
Int J Cancer; 2014 Aug; 135(4):896-904. PubMed ID: 24391021
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
